Key result
Protocol outlines a planned network meta-analysis comparing current therapies for diabetic gastroparesis.
Why the study?
There is no definitive answer as to which current therapy is best for the clinical treatment of diabetic gastroparesis.
What is the best intervention for diabetic patients with gastroparesis?
Systematic Review
What is the best intervention for diabetic patients with gastroparesis?
This protocol outlines a planned network meta-analysis to identify the most effective therapy for diabetic gastroparesis.
Answers are grounded in this paper and cite their sources.
Protocol for network meta-analysis addresses uncertainty in diabetic gastroparesis therapy; leaves optimal intervention open pending completion.
BACKGROUND: Diabetic gastroparesis (DG) is a common autonomic neuropathy which impacts on nutritional state and quality of life in diabetic patients, and it also adversely affects glycemic control in diabetes. The prevalence of DG is growing with the number of patients with diabetes continues to increase. However, there is no definitive answer as to which of the current therapies is the best for the clinical treatment of the different manifestations of DG. The subject of this study is to answer the following question: what is the best intervention for diabetic patients with gastroparesis? METHODS: Comprehensive searches of the Cochrane Library, PubMed, Embase, Medline, Central and Web of Science, and 4 Chinese databases, including China National Knowledge Infrastructure, VIP Database for Chinese Technical Periodicals, Chinese Biomedical Literature Database, and WanFang will be completed using the following keywords DG and therapies and related entry terms. Studies will be included, according to the eligibility criteria (randomized controlled trials and controlled clinical trials, considering specific outcome measures for DG). The reference lists of included studies will be manual searched. Relevant data will be extracted from included studies using a specially designed data extraction sheet. Risk of bias of the included studies will be assessed, and the overall strength of the evidence will be summarized through GRADE. A random effects model will be used for all pairwise meta-analyses (with a 95% confidence interval). A Bayesian network meta-analysis will explore the relative benefits between the various therapies. The review will be reported using the Preferred Reporting Items for Systematic Reviews incorporating Network Meta-Analyses statement. Network meta-analysis will be performed using a Bayesian framework through the Winbugs software. RESULTS: This network meta-analysis will identify the best effective therapy for DG. CONCLUSION: This study will compare and evaluate current therapies for DG, and find the best treatment of DG.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2020) conducted a systematic review in Diabetic gastroparesis. Various therapies vs. Other therapies or control was evaluated. This study is a protocol for a systematic review and network meta-analysis to evaluate and compare current therapies for diabetic gastroparesis; no results are available yet.
Synapse has enriched 10 related papers. Consider them for comparative context: